Literature DB >> 21733660

European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil.

Fernanda T Gonçalves1, Guilherme Francisco, Sonia P de Souza, Olinda C Luiz, Cyro Festa-Neto, José A Sanches, Roger Chammas, Gilka J F Gattas, José Eluf-Neto.   

Abstract

BACKGROUND: UV radiation is the major environmental factor related to development of cutaneous melanoma. Besides sun exposure and the influence of latitude, some host characteristics such as skin phototype and hair and eye color are also risk factors for melanoma. Polymorphisms in DNA repair genes could be good candidates for susceptibility genes, mainly in geographical regions exposed to high solar radiation.
OBJECTIVE: Evaluate the role of host characteristics and DNA repair polymorphism in melanoma risk in Brazil.
METHODS: We carried out a hospital-based case-control study in Brazil to evaluate the contribution of host factors and polymorphisms in DNA repair to melanoma risk. A total of 412 patients (202 with melanoma and 210 controls) were analyzed regarding host characteristics for melanoma risk as well as for 11 polymorphisms in DNA repair genes.
RESULTS: We found an association of host characteristics with melanoma development, such as eye and hair color, fair skin, history of pigmented lesions removed, sunburns in childhood and adolescence, and also European ancestry. Regarding DNA repair gene polymorphisms, we found protection for the XPG 1104 His/His genotype (OR 0.32; 95% CI 0.13-0.75), and increased risk for three polymorphisms in the XPC gene (PAT+; IV-6A and 939Gln), which represent a haplotype for XPC. Melanoma risk was higher in individuals carrying the complete XPC haplotype than each individual polymorphism (OR 3.64; 95% CI 1.77-7.48).
CONCLUSIONS: Our data indicate that the host factors European ancestry and XPC polymorphisms contributed to melanoma risk in a region exposed to high sun radiation.
Copyright © 2011 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733660     DOI: 10.1016/j.jdermsci.2011.06.003

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  15 in total

1.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

2.  Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma.

Authors:  Cristiane Oliveira; José Augusto Rinck-Junior; Gustavo Jacob Lourenço; Aparecida Machado Moraes; Carmen Silvia Passos Lima
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-09       Impact factor: 4.553

3.  Current evidences on the XPG Asp1104His polymorphism and melanoma susceptibility: a meta-analysis based on case-control studies.

Authors:  Yuanzhi Xu; Guangjun Jiao; Li Wei; Ning Wang; Yajun Xue; Jin Lan; Yajie Wang; Chuan Liu; Meiqing Lou
Journal:  Mol Genet Genomics       Date:  2014-09-18       Impact factor: 3.291

4.  XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis.

Authors:  Jinghua Fan; Yuhua Fan; Xiaoxiao Kang; Limin Zhao
Journal:  Oncol Lett       Date:  2015-03-16       Impact factor: 2.967

5.  Exonuclease 1 (EXO1) gene variation and melanoma risk.

Authors:  Fengju Song; Abrar A Qureshi; Jiangwen Zhang; Jiangwen Zhan; Christopher I Amos; Jeffrey E Lee; Qingyi Wei; Jiali Han
Journal:  DNA Repair (Amst)       Date:  2012-01-09

6.  Expression of XPG protein in human normal and tumor tissues.

Authors:  Miguel Aracil; Lisa M Dauffenbach; Marta Martínez Diez; Rana Richeh; Victoria Moneo; Juan Fernando Martínez Leal; Luis Francisco García Fernández; Christopher A Kerfoot; Carlos M Galmarini
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

7.  Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.

Authors:  Ling Zhou; Yuangang Lu; Guihong Yang; Jinjin Wu
Journal:  Tumour Biol       Date:  2013-11-26

8.  A meta-analysis of XPD/ERCC2 Lys751Gln polymorphism and melanoma susceptibility.

Authors:  Yalin Sun; Hao Zhang; Haifeng Ying; Wencheng Jiang; Qiwen Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  Ethnicity and cutaneous melanoma in the city of Sao Paulo, Brazil: a case-control study.

Authors:  Olinda C Luiz; Reinaldo José Gianini; Fernanda T Gonçalves; Guilherme Francisco; Cyro Festa-Neto; José Antonio Sanches; Gilka J F Gattas; Roger Chammas; José Eluf-Neto
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

10.  Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.

Authors:  Mei-Ling Zhu; Mengyun Wang; Zhi-Gang Cao; Jing He; Ting-Yan Shi; Kai-Qin Xia; Li-Xin Qiu; Qing-Yi Wei
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.